Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Abbott Laboratories ."


3 mentions found


A small group of stocks are on the verge of forming a worrisome chart pattern known as a "death cross ." A death cross occurs when a stock's 50-day moving average falls below its 200-day average. Baxter International Stock in medical equipment maker Baxter International is also on the verge of a death cross. Other stocks nearing a death cross chart pattern include Illinois Tool Works and Abbott Laboratories . While the golden cross suggests a potential uptrend, ITW is now approaching the bearish death cross chart pattern only five months later.
Persons: Goldman Sachs, Bonnie Herzog, Clorox, TD Cowen, Joshua Jennings, Baxter, Jennings, Abbott's Organizations: Nasdaq, CNBC, Baxter International Stock, Baxter, Abbott Laboratories ., Tool, Abbott Laboratories, U.S . Food, Drug Administration Locations: Hillrom, Illinois, U.S
CNBC's Jim Cramer on Friday told investors what to look out for in the coming week as earnings season kicks off. "The war will continue to overshadow earnings season, but if you keep track of these companies and there's a cessation in the conflict, the market will eventually embrace the good ones," he said. Cramer will also be watching earnings from consumer packaged goods company Procter & Gamble and medical device maker Abbott Laboratories . Cramer also noted there was "suboptimal commentary" surrounding Netflix and Tesla , which will report Wednesday after the market closes. Cramer will also be looking at Friday reports from American Express and oil service giant SLB , formerly known as Schlumberger.
Persons: CNBC's Jim Cramer, Charles Schwab, Goldman Sachs, Cramer, Charles Schwab's, Lockheed Martin, Johnson, Morgan Stanley Organizations: Bank of America, Lockheed, United Airlines, Procter, Gamble, Abbott Laboratories, Netflix, Tesla, Union Pacific, American Express Locations: Israel, KeyCorp, Schlumberger
A health-care fund with a strong track record could be in a sweet spot for investors who are looking to take some risk off the table, according to Bank of America. "Since 2006, HCES has been a 'goldilocks' trade for investors looking for high-beta healthcare exposure without extreme volatility," the note said. The firm's top-rated ETF in the space is the iShares U.S. Medical Devices ETF (IHI) , which helps investors avoid the volatile biotech stocks found in broader health-care sector funds. IHI 5Y mountain The IHI has averaged a total return of more than 10% over the past five years. In our view, the trade is far less crowded than broad healthcare for investors looking for defensive exposure," Woodard said.
Persons: Jared Woodard, HCES, Woodard, — CNBC's Michael Bloom Organizations: Bank of America . Investment, Medical Devices, Fisher, Abbott Laboratories, Bank of America Locations: U.S
Total: 3